Claritas Pharmaceuticals Short Interest Ratio and Short Volume

Short interest is the volume of Claritas Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 28th, traders have sold 100 shares of KALTF short.

Claritas Pharmaceuticals saw a decrease in short interest in the month of May. As of May 28th, there was short interest totaling 100 shares, a decrease of 99.5% from the previous total of 21,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Claritas Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Claritas Pharmaceuticals: Abattis Bioceuticals Corp. (0.00%), Algernon Pharmaceuticals Inc. (0.00%), Almirall, S.A. (0.00%), Ascletis Pharma Inc. (0.00%), AXIM Biotechnologies, Inc. (0.00%), BerGenBio ASA (0.00%), Cannabics Pharmaceuticals Inc. (0.00%), Cassiopea S.p.A. (0.00%), Cerebain Biotech Corp. (0.00%), and Clinuvel Pharmaceuticals Limited (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($25.04 billion), AstraZeneca PLC ($7.50 billion), Aon plc ($7.09 billion), Square, Inc. ($6.95 billion), Analog Devices, Inc. ($6.90 billion), Advanced Micro Devices, Inc. ($6.79 billion), Charter Communications, Inc. ($6.18 billion), S&P Global Inc. ($5.54 billion), Sea Limited ($4.96 billion), and Wayfair Inc. ($4.25 billion). View all of the most shorted stocks.

Short selling KALTF is an investing strategy that aims to generate trading profit from Claritas Pharmaceuticals as its price is falling. Claritas Pharmaceuticals' stock is trading down $0.00 today. To short Claritas Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Claritas Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Claritas Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KALTF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALTF, twice per month. The most recent reporting period available is May, 28 2021.